Please use this identifier to cite or link to this item:
|Title:||Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein||Authors:||Notkins, Abner L.
Yoon, Ho Sup
Kim, Ki Hwan
|Keywords:||DRNTU::Science::Biological sciences::Microbiology::Virology||Issue Date:||1998||Source:||Jun, H. S., Kang, Y., Yoon, H. S., Kim, K. H., Notkins, A. L. & Yoon, J. W. (1998). Determination of Encephalomyocarditis Viral Diabetogenicity by a Putative Binding Site of the Viral Capsid Protein. Diabetes, 47(4), 576-582.||Series/Report no.:||Diabetes||Abstract:||The molecular mechanism by which some, but not all, variants of encephalomyocarditis (EMC) virus selectively infect pancreatic beta-cells in mice and induce IDDM has been an enigma for more than a decade. We report here that the binding site of the EMC viral capsid protein VP1 determines viral diabetogenicity. Recombinant chimeric EMC viruses containing threonine, serine, proline, aspartic acid, or valine at position 152 of the major capsid protein VP1 bind poorly to beta-cells. In contrast, recombinant chimeric EMC viruses containing alanine or glycine at position 152 of the VP1 bind efficiently to and infect beta-cells, resulting in the development of diabetes. Three-dimensional molecular modeling reveals that the van der Waals interactions are greater and the residues surrounding position 152 of the VP1 are more closely packed in recombinant chimeric viruses containing threonine, serine, proline, aspartic acid, or valine at position 152 than in recombinant chimeric viruses containing alanine or glycine at the same position. Our studies reveal that the surface areas surrounding alanine or glycine at position 152 of the VP1 are more accessible, thus increasing the availability of the binding sites for attachment to beta-cell receptors and resulting in viral infection and the development of diabetes.||URI:||https://hdl.handle.net/10356/94163
|DOI:||10.2337/diabetes.47.4.576||Rights:||© 1998 American Diabetes Association. This is the author created version of a work that has been peer reviewed and accepted for publication by Diabetes, American Diabetes Association. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: http://dx.doi.org/10.2337/diabetes.47.4.576||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||SBS Journal Articles|
Files in This Item:
|36. Determination of Encephalomyocarditis Viral Diabetogenicity by.pdf||496.54 kB||Adobe PDF|
Updated on Mar 14, 2023
Web of ScienceTM
Updated on Mar 21, 2023
Page view(s) 51,147
Updated on Mar 22, 2023
Updated on Mar 22, 2023
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.